2022.09.27
未分類
Website Renewal
NEWS
What's new
MESSAGE
Message from the Representative director
We will contribute to medical care
Delawave will continue to develop new medical devices and deliver them to the world, thereby contributing to medical care from the aspect of technology.
We value honesty and will continue to take on challenges, despite difficulties, to develop and provide medical devices that are useful to patients and healthcare professionals. We look forward to your continued support for DELAWAVE.
Kenji Taira, Representative Director, Delawave, Inc.
COMPANY
Company Information
We are a technology-based startup developing medical devices for coronary arteries
Our solution is a coronary imaging catheter and system for CAD treatment.
SERVICE
Project Overview
Introducing Delawave's coronary artery disease (CAD) treatment project
Approved by the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan in March 2021
・Intravascular Optical Coherence Tomography (OCT) catheter
・OCT diagnostic imaging system
RECRUIT
Career Recruitment
Delawave is looking for a highly passionate talent who can make use of the experience they have accumulated and work together with us.
CONTACT
Contact Us
If you have any questions about our company Please contact us using the form below